Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - GUIDED THERAPEUTICS INC | ex99one.htm |
| EX-99.2 - GUIDED THERAPEUTICS FOURTH QUARTER 2015 CONFERENCE CALL SCRIPT - GUIDED THERAPEUTICS INC | ex99two.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 15, 2016 (March 14, 2016)
GUIDED THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
|
Delaware (State or other jurisdiction of incorporation) |
0-22179 (Commission File Number) |
58-2029543 (IRS Employer Identification No.) | |||
|
5835 Peachtree Corners East, Suite D Norcross, Georgia (Address of principal executive offices) |
30092 (Zip Code) | ||||
Registrant’s telephone number, including area code: (770) 242-8723
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
| |
| [ ] |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
| |
| [ ] |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
| |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| 1 |
Section 2.02 Results of Operations and Financial Condition
On March 14, 2016, the registrant publicly released its financial results for the fourth quarter and year ended December 31, 2015, as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto and which information is incorporated herein by reference.
Item 7.01 Regulation FD Disclosure
On March 15, 2016, the registrant conducted a conference call discussing its financial results for the fourth quarter and year ended December 31, 2015, and other matters concerning the operation of the company, as more fully described in the prepared transcript of the call, a copy of which is furnished as Exhibit 99.2 hereto and which information is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
| Number | Exhibit | |
| 99.1 | Press Release dated March 14, 2015 | |
| 99.2 | Call transcript |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GUIDED THERAPEUTICS, INC. | |
| /s/ Gene S. Cartwright_______________________ | |
| By: Gene S. Cartwright, Ph.D. | |
| President and Chief Executive Officer | |
| Date: March 15, 2016 |
| 3 |
EXHIBIT INDEX
| Number | Exhibit | |
| 99.1 | Press Release dated March 14, 2016 | |
| 99.2 | Call transcript |
| 4 |